A Novel Use of a Statewide Telecolposcopy Network for Recruitment of Participants in a Phase I Clinical Trial of a Human Papillomavirus Therapeutic Vaccine

類似資料

• Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination
  著者:: Coleman, Hannah N., 等
  出版事項: (2016)
• Distribution of Human Papillomavirus (HPV) Types and Anti-HPV T-Cell Immune Responses Among Different Racial/Ethnic Groups in Central Arkansas
  著者:: Nakagawa, Mayumi, 等
  出版事項: (2013)
• A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
  著者:: Greenfield, William W, 等
  出版事項: (2015)
• CD4+ T-Cell Response Against Human Papillomavirus Type 16 E6 Protein Is Associated with A Favorable Clinical Trend
  著者:: Kim, Kevin H., 等
  出版事項: (2011)
• Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine
  著者:: Wang, Xuelian, 等
  出版事項: (2013)